Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch-Reference-Cited by-同舟云学术

Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch

Published:2013-04-10 Issue:12 Volume:119 Page:2230-2238
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chen Yong¹,Sun Ying¹,Liang Shao-Bo²,Zong Jing-Feng³,Li Wen-Fei¹,Chen Mo¹,Chen Lei¹,Mao Yan-Ping¹,Tang Ling-Long¹,Guo Ying⁴,Lin Ai-Hua⁵,Liu Meng-Zhong¹,Ma Jun¹

Affiliation:

1. State Key Laboratory of Oncology in South China; Department of Radiation Oncology; Sun Yat-sen University Cancer Center; Guangzhou People's Republic of China

2. Department of Radiation Oncology; Cancer Center, The First People's Hospital of Foshan; Foshan People's Republic of China

3. Department of Radiation Oncology; Fujian Provincial Tumor Hospital; Fuzhou People's Republic of China

4. Clinical Trials Center; Sun Yat-sen University Cancer Center; Guangzhou People's Republic of China

5. Department of Medical Statistics and Epidemiology; School of Public Health, Sun Yat-sen University; Guangzhou People's Republic of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28049/fullpdf

Reference26 articles.

1. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?;Ma;Int J Radiat Oncol Biol Phys,2001

2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup Study 0099;Al-Sarraf;J Clin Oncol,1998

3. Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: progress report [abstract];Al-Sarraf;J Clin Oncol,1998

4. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of 2 phase III trials;Chua;J Clin Oncol,2005

5. The national cancer data base report on the relationship of race and national origin to the histology of race and national origin to the histology of nasopharyngeal carcinoma;Marks;Cancer,1998

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

2. Asparaginase and isoaspartyl peptidase 1 RNA interference suppresses the growth of nasopharyngeal carcinoma cells;2023-12-25

3. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma;Holistic Integrative Oncology;2023-07-24

4. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis;The Lancet Oncology;2023-06

5. Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancer;BMC Medical Imaging;2023-05-30